SPASS gets FDA clearance for AI-based sepsis diagnosis s…
credit : SPASS, SPASS, a Korean company specializing in artificial intelligence (AI) medical solutions, said its AI-based sepsis diagnosis solution, SpassageQ, has received FDA 510(k) clearance, also known as pre-market notification, local news reports said. SPASS, a company specializing in artificial intelligence medical solutions, said on Tuesday that its AI-based sepsis diagnosis solution, SpassageQ, has received 510(k) approval also known as pre-market notification from the FDA. The approval of the AI-based sepsis diagnosis software, SpassageQ, demonstrates that the field of medical AI sol
- SPASS Reporter
- 2023-06-21 01:19